TOXSTA
LIVE

Serial Number

79291052

Owner

JETEMA CO., LTD.

Attorney

Benjamin M. Cantor

Filing Date

Jun 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TOXSTA Trademark

Serial Number: 79291052 • Registration: 6430556

TOXSTA is a trademark filed by JETEMA CO., LTD. on June 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

JETEMA CO., LTD. (16 trademarks)

15TH FLOOR, 623, TEHERAN-RO, GANGNAM-GU
SEOUL 06173 , KR

Entity Type: 99

Trademark Details

Filing Date

June 3, 2020

Registration Date

July 27, 2021

Published for Opposition

May 11, 2021

Goods & Services

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating cramps; pharmaceutical preparations for treating muscle; pharmaceutical preparations for treating cerebral palsy; pharmaceutical preparations for treating hyperhidrosis; pharmaceutical agents affecting metabolism; bacteria poisons; Pharmaceutical preparations for treating headache; anaesthetics; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for urogenital organs; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries and pain, namely, pharmaceuticals containing botulinum toxin; Cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives used to treat neurological diseases; Ophthalmic preparations; allergy medications; Chemical preparations for pharmaceutical purposes, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical agents for epidermis; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for skincare in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; pharmaceutical preparations for skin care treatment in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; medicines for human purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical preparations for orthopedic purposes; pharmaceutical preparations for treating wrinkles; analgesic preparations; medicines for dental purposes; pharmaceutical preparations for treating pain; pharmaceutical preparation for skin care; medicated preparations for skin treatment; pharmaceutical preparations for respiratory organs; preparations for the treatment of burns; preparations for the treatment of scar

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 6, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 1, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 13, 2021 FICS
FINAL DISPOSITION PROCESSED
Dec 13, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2021 R.PR
NOTIFICATION PROCESSED BY IB
May 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 11, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 21, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 21, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2021 NREP
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 1, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 6, 2020 REPR